https://phlabs.co.uk/assets/research.cjc-1295-ipamorelin-synergy-DktfAraa.js

1import{j as e}from"./vendor-react-HWeamStq.js";import{C as a}from"./vendor-tanstack-Ct9BrFqm.js";import"./vendor-tslib-BWHQfYT7.js";const t=[{citation:"Teichman S.L. et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. J Clin Endocrinol Metab.",doi:"10.1210/jc.2005-1536"},{citation:"Sackmann-Sala L. et al. (2009). Activation of the GH/IGF-1 axis by CJC-1295 analogues. Growth Horm IGF Res.",doi:"10.1016/j.ghir.2009.07.004"},{citation:"Raun K. et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol.",doi:"10.1530/eje.0.1390552"},{citation:"Bowers C.Y. (2005). Growth hormone-releasing peptides (GHRPs) — historical perspective and mechanisms. Endocrine.",doi:"10.1385/ENDO:26:3:263"},{citation:"Alba M. et al. (2006). Once-daily administration of CJC-1295 increases 24-h GH and IGF-I levels — synergy with GHRP class. Growth Horm IGF Res.",doi:"10.1016/j.ghir.2006.02.002"}];function n(){return e.jsx("main",{className:"min-h-screen bg-slate-950 text-slate-100",children:e.jsxs("article",{className:"mx-auto max-w-4xl px-4 py-12 sm:px-6 lg:py-16",children:[e.jsxs("nav",{"aria-label":"Breadcrumb",className:"mb-6 text-sm text-slate-400",children:[e.jsx("a",{href:"/",className:"hover:text-emerald-400",children:"Home"}),e.jsx("span",{className:"mx-2",children:"/"}),e.jsx("a",{href:"/research",className:"hover:text-emerald-400",children:"Research"}),e.jsx("span",{className:"mx-2",children:"/"}),e.jsx("span",{className:"text-slate-200",children:"CJC-1295 & Ipamorelin Synergy"})]}),e.jsxs("header",{className:"mb-10",children:[e.jsx("p",{className:"mb-3 inline-block rounded-full bg-emerald-950/60 px-3 py-1 text-xs font-semibold uppercase tracking-wider text-emerald-300",children:"Synergy Research Guide"}),e.jsx("h1",{className:"text-4xl font-bold leading-tight sm:text-5xl",children:"CJC-1295 & Ipamorelin Synergy — UK GHRH / GHRP Research Guide"}),e.jsx("p",{className:"mt-4 text-lg text-slate-200",children:"How UK laboratories study CJC-1295 (GHRH analogue) and Ipamorelin (selective GHRP / ghrelin-receptor agonist) together in combined pituitary secretagogue panels. CJC-1295 activates the GHRH-R / Gs / cAMP axis; Ipamorelin activates the GHS-R1a / Gq / calcium axis. Together they span the two dominant preclinical readouts in somatotroph secretagogue research."}),e.jsx("p",{className:"mt-3 text-sm font-semibold uppercase tracking-wide text-amber-300",children:"For Research Use Only. Not for Human Consumption."})]}),e.jsxs("section",{className:"mb-10 rounded-xl border border-slate-800 bg-slate-900 p-6",children:[e.jsx("h2",{className:"mb-4 text-2xl font-semibold",children:"At a glance — combined panel design"}),e.jsxs("div",{className:"grid gap-6 sm:grid-cols-2",children:[e.jsxs("div",{children:[e.jsx("h3",{className:"mb-2 text-lg font-semibold text-emerald-300",children:"CJC-1295 — GHRH arm"}),e.jsxs("ul",{className:"list-disc space-y-1 pl-5 text-sm text-slate-200",children:[e.jsx("li",{children:"Receptor: GHRH-R (Gs-coupled)"}),e.jsx("li",{children:"Cascade: adenylyl cyclase → cAMP → PKA"}),e.jsx("li",{children:"Readout: cAMP accumulation, GH-pool priming"}),e.jsx("li",{children:"Working range: 1 nM – 1 µM (DAC form: 24–72 h exposure)"})]})]}),e.jsxs("div",{children:[e.jsx("h3",{className:"mb-2 text-lg font-semibold text-emerald-300",children:"Ipamorelin — GHRP arm"}),e.jsxs("ul",{className:"list-disc space-y-1 pl-5 text-sm text-slate-200",children:[e.jsx("li",{children:"Receptor: GHS-R1a (Gq-coupled)"}),e.jsx("li",{children:"Cascade: PLC → IP3 / DAG → intracellular Ca²⁺"}),e.jsx("li",{children:"Readout: Calcium mobilisation, acute GH exocytosis"}),e.jsx("li",{children:"Working range: 1 nM – 1 µM"})]})]})]})]}),e.jsxs("section",{className:"mb-10",children:[e.jsx("h2",{className:"mb-3 text-2xl font-semibold",children:"Why study them together?"}),e.jsx("p",{className:"text-slate-200",children:"In preclinical pituitary research, growth-hormone release is regulated by two orthogonal ligand classes: GHRH (Gs-coupled) and the GHRP / ghrelin family (Gq-coupled). CJC-1295 anchors the Gs / cAMP axis (Teichman et al., 2006); Ipamorelin anchors the Gq / calcium axis (Raun et al., 1998). Running both as parallel positive controls gives a laboratory a two-axis mechanistic map — any novel test compound can be positioned as GHRH-like, GHRP-like, dual, or novel."}),e.jsx("p",{className:"mt-3 text-slate-200",children:"This is particularly valuable in UK contract-research settings where characterising a new synthetic peptide requires rapid mechanistic triage. A combined CJC-1295 / Ipamorelin reference panel delivers both G-protein readouts in a single experimental design instead of sequential single-pathway screens."})]}),e.jsxs("section",{className:"mb-10",children:[e.jsx("h2",{className:"mb-3 text-2xl font-semibold",children:"Typical combined-panel protocol"}),e.jsx("p",{className:"text-slate-200",children:"A standard four-arm design used in UK research laboratories:"}),e.jsxs("ol",{className:"mt-3 list-decimal space-y-2 pl-6 text-slate-200",children:[e.jsxs("li",{children:[e.jsx("strong",{className:"text-slate-100",children:"Vehicle control:"})," Sterile bacteriostatic water in the same solvent ratio as the test compound."]}),e.jsxs("li",{children:[e.jsx("strong",{className:"text-slate-100",children:"CJC-1295 reference:"})," 100 nM — sub-maximal but robust GHRH-R activation for cAMP / GH-pool priming readouts."]}),e.jsxs("li",{children:[e.jsx("strong",{className:"text-slate-100",children:"Ipamorelin reference:"})," 100 nM — sub-maximal but robust GHS-R1a activation for calcium / acute GH-release readouts."]}),e.jsxs("li",{children:[e.jsx("strong",{className:"text-slate-100",children:"Test compound:"})," Matched concentration alongside both references. Normalise all data to vehicle, then to each individual reference."]})]}),e.jsx("p",{className:"mt-3 text-slate-200",children:"Endpoints typically include cAMP HTRF, Fluo-4 calcium imaging, GH ELISA on culture supernatant, and time-resolved GH-secretion profiles from GH3 / GH4C1 somatotroph lines. Each endpoint is read against the corresponding CJC-1295 or Ipamorelin positive control to assign mechanism."})]}),e.jsxs("section",{className:"mb-10",children:[e.jsx("h2",{className:"mb-3 text-2xl font-semibold",children:"Mechanistic deconvolution in practice"}),e.jsx("p",{className:"text-slate-200",children:"When a novel test peptide is screened against the combined panel, the observed response pattern falls into one of four mechanistic categories:"}),e.jsxs("ul",{className:"mt-3 list-disc space-y-2 pl-6 text-slate-200",children:[e.jsxs("li",{children:[e.jsx("strong",{className:"text-slate-100",children:"GHRH-like profile:"})," Mimics CJC-1295 (cAMP ↑, calcium minimal). Gs / GHRH-R mechanism dominant."]}),e.jsxs("li",{children:[e.jsx("strong",{className:"text-slate-100",children:"GHRP-like profile:"})," Mimics Ipamorelin (calcium ↑, cAMP minimal). Gq / GHS-R1a mechanism dominant."]}),e.jsxs("li",{children:[e.jsx("strong",{className:"text-slate-100",children:"Dual profile:"})," Elevates both endpoints. Suggests dual-receptor engagement or a downstream signalling node shared by both arms; further antagonist deconvolution required."]}),e.jsxs("li",{children:[e.jsx("strong",{className:"text-slate-100",children:"Novel profile:"})," Does not align with either reference. Indicates a distinct mechanism — valuable for follow-up target-identification work."]})]})]}),e.jsxs("section",{className:"mb-10",children:[e.jsx("h2",{className:"mb-3 text-2xl font-semibold",children:"Storage, handling and reconstitution"}),e.jsx("p",{className:"text-slate-200",children:"Both CJC-1295 (with or without DAC) and Ipamorelin are supplied as lyophilised powders. For combined-panel consistency, reconstitute from the same solvent batch (sterile bacteriostatic water) on the day of assay setup. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles. Store lyophilised vials at −20 °C; discard any vial that has undergone more than three freeze-thaw cycles. Use batch-matched COAs to confirm purity (HPLC ≥ 99.0%) and identity (LC-MS) before assay inclusion."})]}),e.jsxs("section",{className:"mb-10 rounded-xl border border-slate-800 bg-slate-900 p-6",children:[e.jsx("h2",{className:"mb-4 text-2xl font-semibold",children:"Source both reference peptides for your combined panel"}),e.jsx("p",{className:"text-slate-200",children:"PH Labs supplies CJC-1295 (with DAC and without DAC / Mod GRF 1-29) and Ipamorelin as HPLC-verified lyophilised reference compounds for UK in-vitro pituitary-secretagogue research. Every batch ships with a Certificate of Analysis (HPLC ≥ 99.0%, LC-MS identity, residual solvents, water content, endotoxin) for inclusion as rigorously characterised positive controls in combined-panel designs."}),e.jsxs("div",{className:"mt-5 flex flex-wrap gap-3",children:[e.jsx("a",{href:"/products",className:"rounded-lg bg-emerald-600 px-5 py-3 font-semibold text-white hover:bg-emerald-500",children:"Browse research peptides →"}),e.jsx("a",{href:"/research",className:"rounded-lg border border-slate-700 px-5 py-3 font-semibold text-slate-100 hover:border-emerald-400 hover:text-emerald-300",children:"More research guides"})]})]}),e.jsxs("section",{className:"mb-10",children:[e.jsx("h2",{className:"mb-4 text-2xl font-semibold",children:"Frequently asked questions"}),e.jsx("dl",{className:"space-y-4",children:a.map(s=>e.jsxs("div",{className:"rounded-lg border border-slate-800 bg-slate-900 p-5",children:[e.jsx("dt",{className:"text-lg font-semibold text-slate-100",children:s.q}),e.jsx("dd",{className:"mt-2 text-slate-200",children:s.a})]},s.q))})]}),e.jsxs("section",{className:"mb-10",children:[e.jsx("h2",{className:"mb-3 text-2xl font-semibold",children:"References"}),e.jsx("ol",{className:"list-decimal space-y-2 pl-6 text-sm text-slate-300",children:t.map(s=>e.jsxs("li",{children:[s.citation,s.doi&&e.jsxs(e.Fragment,{children:[" ",e.jsxs("a",{className:"text-emerald-300 hover:underline",href:`https://doi.org/${s.doi}`,rel:"noopener nofollow",target:"_blank",children:["doi:",s.doi]})]})]},s.citation))})]}),e.jsx("footer",{className:"mt-12 border-t border-slate-800 pt-6 text-xs text-slate-400",children:e.jsxs("p",{children:["This page is a technical research guide for UK laboratories. PH Labs supplies CJC-1295 and Ipamorelin strictly as reference materials for in-vitro work and analytical use. ",e.jsx("strong",{children:"For Research Use Only. Not for Human Consumption."})]})})]})})}export{n as component};